## Abstract Women with a mutation in __BRCA1__ or __BRCA2__ face a lifetime risk of breast cancer of βΌ80%, and following the first diagnosis the10βyear risk of contralateral breast cancer is βΌ30%. It has been shown that both tamoxifen and oophorectomy prevent contralateral breast cancer, but it is
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update
β Scribed by Ophira Ginsburg; Parviz Ghadirian; Jan Lubinski; Cezary Cybulski; Henry Lynch; Susan Neuhausen; Charmaine Kim-Sing; Mark Robson; Susan Domchek; Claudine Isaacs; Jan Klijn; Susan Armel; William D. Foulkes; Nadine Tung; Pal Moller; Ping Sun; Steven A. Narod; Hereditary Breast Cancer Clinical Study Group
- Publisher
- Springer US
- Year
- 2008
- Tongue
- English
- Weight
- 251 KB
- Volume
- 114
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Although there are several plausible biologic mechanisms whereby coffee consumption might influence the risk of breast cancer, epidemiologic evidence is limited. We assessed the association between coffee consumption and breast cancer risk among highβrisk women who carry __BRCA__ mutati
## Abstract The effect of cigarette smoking on the risk of breast cancer is controversial, although most studies show little or no effect. It has been suggested that smoking may reduce the risk of developing hereditary breast cancer. We completed a caseβcontrol study on 1,097 women with breast canc
## Abstract Marked variation in phenotypic expression among __BRCA1__ and __BRCA2__ mutation carriers may be partly explained by modifier genes that influence mutation penetrance. Variation in CAG/CAA repeat lengths coding for stretches of glutamines in the Cβterminus of the AIB1 protein (amplified